LN-Tab 10 Tablet contains Cilnidipine 10mg, a calcium channel blocker used primarily in the management of hypertension. Cilnidipine exerts its antihypertensive effect by inhibiting the influx of calcium ions through L-type and N-type calcium channels in vascular smooth muscle and sympathetic nerve endings, leading to vasodilation and reduced peripheral vascular resistance. This dual action not only lowers blood pressure but also attenuates sympathetic nerve activity, which may provide additional cardiovascular protection. LN-Tab 10 is indicated for the treatment of essential hypertension and can be used as monotherapy or in combination with other antihypertensive agents to achieve optimal blood pressure control. The medication is generally well tolerated; however, common adverse effects may include headache, dizziness, flushing, and peripheral edema. Caution is advised in patients with severe hepatic impairment, and it should be used with care in those with hypotension or heart failure. Regular monitoring of blood pressure and renal function is recommended during therapy. LN-Tab 10 should be taken as prescribed by a healthcare professional, and patients are advised not to discontinue treatment abruptly to avoid rebound hypertension. This medication contributes effectively to cardiovascular risk reduction by maintaining target blood pressure levels.